Efficacy Study of Comprehensive Rehabilitation Program Plus Chemotherapy in Postoperative NSCLC Patients
Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The investigators performed a multi-centered, randomized, placebo-controlled, prospective
clinical trial on the effect of comprehensive rehabilitation program plus chemotherapy to
improve quality of life(QOL) and long-term survival of postoperative non small cell lung
cancer（NSCLC）patients with high risk stages IB to IIIA. The investigators plan to enroll 354
cases in 3 years (118 cases for chemotherapy plus rehabilitation training and traditional
Chinese medicine (TCM), 118 cases for chemotherapy plus rehabilitation education and TCM,118
cases for chemotherapy plus rehabilitation education and placebo), expecting that
comprehensive rehabilitation program plus chemotherapy has a better efficacy on improving QOL
and long-term survival.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Collaborators:
Huadong Hospital Shanghai Cancer Hospital, China Shanghai Chest Hospital Shanghai Pulmonary Hospital, Shanghai, China